In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens | Zendy

Fernando Baquero | Zendy; Rafael Cantón | Zendy

Open Access

In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens

Author(s) -

Fernando Baquero,

Rafael Cantón

Publication year - 1996

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/37.suppl_a.1

Subject(s) - sparfloxacin , antimicrobial , respiratory tract infections , streptococcus pneumoniae , respiratory tract , microbiology and biotechnology , antibiotics , penicillin , medicine , respiratory system , biology , ofloxacin , ciprofloxacin

Bacterial resistance to antimicrobial agents is an ever-increasing problem. The in-vitro activity of sparfloxacin compared with that of currently available antimicrobial agents against pathogens implicated in respiratory tract infections is reviewed. Sparfloxacin is a fluoroquinolone active against both penicillin-susceptible and -resistant strains of Streptococcus pneumoniae. It is also active against many other respiratory tract pathogens and may be a suitable alternative for empirical therapy of community-acquired respiratory tract infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research